Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Elan looks again at hiving off drug delivery unit EDT

April 22, 2010 Research and Development, Sales and Marketing Elan

Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …
News
BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010 Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …
Appointment

Astellas eyes oncology growth

April 21, 2010 Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …
News

GSK’s Arzerra conditionally approved in Europe

April 20, 2010 Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …
News

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010 Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …
News

Trial boost for Merck KGaA’s cladribine

April 19, 2010 Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
News

MedImmune: building a biologics future

April 19, 2010 Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Feature

Action Pharma appoints new chief executive

April 19, 2010 Research and Development Action Pharma, appointment, research and development

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Appointment

Lixisenatide scores in phase III trial

April 15, 2010 Research and Development GLP-1, Lixisenatide, diabetes

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …
News

Roche buys insulin patch company

April 13, 2010 Research and Development Diagnostics, Roche, diabetes

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …
News
AquapharmSimonBest

Dr Simon Best joins Aquapharm as chief executive

April 13, 2010 Research and Development Aquapharm, Aquapharm Biodiscovery, appointment, research and development

Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …
Appointment

Parexel launches software for post-approval trials

April 12, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel has launched a new web-based technology platform for late phase clinical research that it says makes …
News

Contract research news in brief

April 12, 2010 Research and Development Ingenix, Medpace, NIB, NexMed, RDNIB

A round-up of recent developments in the clinical research arena includes an expansion for NexMed’s pre-clinical division, acquisitions for Medpace …
News

Italy’s new R&D centre launched by Burns

April 9, 2010 Research and Development Italy

The recently retired head of Roche’s pharma division has called for more public-private partnerships in the pharma industry. William Burns …
News

Sanofi-Aventis signs drug with potential to reverse diabetes

April 9, 2010 Research and Development Sanofi, diabetes

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026